State Support for the Industrial Production of Active Pharmaceutical Substances in the Russian Federation

View Full Paper

Ask AI

Bookmark

Production costs and insufficient infrastructure hamper active pharmaceutical substances development in Russia, making government initiatives crucial.
Between 2014 and 2024, key trends in the pharmaceutical industry show a push for import substitution alongside technological advancements.
This observational analysis assesses the effectiveness of subsidy programs and tax incentives in increasing domestic production capacity.
Understanding these dynamics is essential for strengthening the pharmaceutical sector, indicating a need for further government action.

Discussion

No takes yet. Share an insight, caveat, or question.

Analysis reveals challenges in the active pharmaceutical substances market, highlighting government support effectiveness.

A.S. et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark